Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Utility of methylene blue for the reversal of excessive levels of methemoglobin

Technical Report ·
OSTI ID:7234863

Many new prophylactic and therapeutic compounds are being studied as potential sources of methemoglobin useful in counteracting the lethal effects of cyanide intoxication. The formation of methemoglobin also leads to a reduction in the blood oxygen carrying capacity which may, in extreme cases, lead to lethal consequences. The i.v. administration of Methylene blue rapidly reverses methemoglobin to hemoglobin. Unanticipated high levels of methemoglobin (65 - 85%) in three sheep exposed to propiophenone derivatives led to a lethal outcome in one untreated sheep and complete recovery in two sheep which were treated with 3.0 mg/kg methylene blue i.v. methemoglobin was reduced to safe levels within minutes following administration. A similar exposure of dogs to propriophenone derivatives led to high levels (77 - 78%) of methemoglobin which were readily reversed following the intravenous administration of the same dose of methylene blue.

Research Organization:
Food and Drug Administration, Rockville, MD (United States)
OSTI ID:
7234863
Report Number(s):
AD-P-008851/8/XAB
Country of Publication:
United States
Language:
English